Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.51 |
| ▸ | AGER | Q15109 | 1/20 | 0.51 |
| ▸ | FDPS | P14324 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9022668 | 0.98 | CYP19A1 (0.50) | CYP19A1AGERFDPS | |
| Water SCHEMBL9022662 | 0.98 | CYP19A1 (0.50) | CYP19A1AGERFDPS | |
| SCHEMBL10247560 | 0.87 | AGER (0.62) | CYP19A1AGERFDPS | |
| Hydrochloric Acid SCHEMBL1775858 | 0.85 | AGER (0.60) | CYP19A1AGERFDPS | |
| SCHEMBL11292777 | 0.82 | AGER (0.53) | CYP19A1AGERFDPS | |
| SCHEMBL1585079 | 0.82 | AGER (0.53) | CYP19A1AGERFDPS | |
| SCHEMBL10730735 | 0.82 | AGER (0.53) | CYP19A1AGERFDPS | |
| SCHEMBL6003232 | 0.80 | FDPS (0.55) | CYP19A1AGERFDPS | |
| SCHEMBL412063 | 0.80 | AGER (0.51) | CYP19A1AGERFDPS | |
| Hydrochloric Acid SCHEMBL11288977 | 0.80 | AGER (0.51) | CYP19A1AGERFDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117377651-B | Cationic lipid with side chain containing functional groups and application thereof | 厦门赛诺邦格生物科技股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2025-01-30 | — | — | US | disclosed |
| EP-4458805-A1 | CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2024-11-06 | — | — | EP | disclosed |
| CN-117377651-A | Cationic lipid with side chain containing functional groups and application thereof | 厦门赛诺邦格生物科技股份有限公司 | 2024-01-09 | — | — | CN | disclosed |
| WO-2023126006-A1 | CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF | 厦门赛诺邦格生物科技股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
| US-20150126679-A1 | POLYMERIZABLE BENZOXAZINE COMPOUNDS WITH INTERFACIAL ACTIVE OR SURFACE ACTIVE PROPERTIES | HENKEL AG & CO KGAA (DE) | 2015-05-07 | — | — | US | disclosed |
| US-20150126669-A1 | POLYMERIZABLE BENZOXAZINE COMPOUNDS WITH INTERFACIAL ACTIVE OR SURFACE ACTIVE PROPERTIES | HENKEL AG & CO KGAA (DE) | 2015-05-07 | — | — | US | disclosed |
| EP-2430073-B1 | CATIONIC BENZOXAZINE (CO)POLYMERS | HENKEL AG & CO KGAA (DE) | 2015-01-07 | — | — | EP | disclosed |
| EP-2430137-B1 | COLOR-PROTECTING WASHING OR CLEANING AGENT | HENKEL AG & CO KGAA (DE) | 2014-11-12 | — | — | EP | disclosed |
| US-8580726-B2 | Color-protecting washing or cleaning agent | HENKEL AG & CO. KGAA (DE) | 2013-11-12 | — | — | US | disclosed |
| WO-2010018198-A1 | POLYMERIZABLE BENZOXAZINE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2010-02-18 | — | — | WO | disclosed |
| CN-101400656-A | Piperazine derivatives as farnesyl protein transferase inhibitors | SCHERING CORP (US) | 2009-04-01 | — | — | CN | disclosed |
| US-20070213340-A1 | Farnesyl protein transferase inhibitors | SCHERING CORPORATION | 2007-09-13 | — | — | US | disclosed |
| US-20070213340-A1 | Farnesyl protein transferase inhibitors | SCHERING CORPORATION | 2007-09-13 | — | — | US | disclosed |
| WO-2007084498-A1 | PIPERAZINE DERIVATIVES AS FARNESYL PROTEIN TRANSFERASE INHIBITORS | SCHERING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
| CN-1326850-C | Tricyclic farnesyl protein transferase inhibitors | SCHERING CORP (US) | 2007-07-18 | — | — | CN | disclosed |
| CN-1334811-A | Tricyclic farnesyl protein transferase inhibitors | SCHERING CORP (US) | 2002-02-06 | — | — | CN | disclosed |
| EP-0705251-A1 | IMIDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS | Knoll AG (DE) | 1996-04-10 | — | — | EP | disclosed |
| US-5081131-A | Omega-((hetero)alkyl)benz(cd)-indol-2-amines | AMERICAN CYANAMID COMPANY (US) | 1992-01-14 | — | — | US | disclosed |
| EP-0230035-A2 | Omega-[(hetero)alkyl]benz[cd]indol-2-amines | AMERICAN CYANAMID COMPANY (US) | 1987-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126679-A1 | POLYMERIZABLE BENZOXAZINE COMPOUNDS WITH INTERFACIAL ACTIVE OR SURFACE ACTIVE PROPERTIES | CYP4Z1, PRDX4, PRDX1 | CYP19A1 291/4885AGER 2366/4885FDPS 1566/4885 |
| US-20070213340-A1 | Farnesyl protein transferase inhibitors | FNTB, FNTA, FDPS | CYP19A1 1629/4885AGER 3807/4885FDPS 3/4885 |
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | PHOSPHO1, LIPA, SLC7A1 | CYP19A1 3836/4885AGER 3492/4885FDPS 4632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.